Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NAGE compared with DFTX: revenue, margins and what each company keeps, and the suppliers and customers both name
NAGE
Niagen Bioscience, Inc.
Change
Mkt cap
Revenue
Revenue
DFTX
Definium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NAGE
Niagen Bioscience, Inc.
vs
DFTX
Definium Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
NAGE
with
DFTX
Uncorrelated: r 0.10 · 499D.
No shared co-movers.
NAGE, solid
DFTX, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
NAGE
Niagen Bioscience, Inc.
Change
2.11
▼
−16.27%
· post 2.11
Mkt cap
$166.7M
Revenue
$27M
Q3 FY26
Revenue
$129M
FY25
DFTX
Definium Therapeutics, Inc.
Change
30.34
▼
−7.21%
· post 30.39
Closed
Nov 5 '26
Mkt cap
$4.4B
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 5 '26
NAGE
Niagen Bioscience, Inc.
vs
DFTX
Definium Therapeutics, Inc.
2.11
▼
−16.27%
post 2.11
Price
30.34
▼
−7.21%
post 30.39
$166.7M
Mkt cap
$4.4B
Q3 FY26
$27M
Revenue
—
FY25
$129M
Revenue
—
Change
Change
NAGE
2.11
▼
−16.27%
vs
DFTX
30.34
▼
−7.21%
Closed
Nov 5 '26